Female Genital Tract 3 Flashcards
ovarian follicle and luteal cysts
unruptured graafian follicles or ruptured follicle that immediately seals
- multiple, small (1 cm), filled with clear serous fluid
- sometimes large 4-5 cm
PCOS Characterized by Pathogenesis Histology Clinical Sequela Treatment
Characterized by:
- excess secretion of androgenic hormones
- persistent anovulation
- many subcapsular ovarian cysts–enlarged ovaries
Pathogenesis: Increased secretion of LH Insulin resistant hyperinsulinism 1. LH>FSH 2. Increased androgens 3. converted to estrones 4. Decreased FSH 5. Cystic follicle degeneration 6. Follicular cysts
Histology
- follicles lined by granulosa cells with hyperplastic theca (interna)
- theca cells produce androgens
Clinical
Reproductive, metabolic, cardiovascular
1. Hirsutism
2. chronic anovulation, oligomenorrhea, infertility
3. insulin resistance
4. obesity
5. endometrial hyperplasia, endometrioid cancer
Treatment
- Weight reduction
- Hormone therapy to interrupt constant excess of androgens
- Metformin
- DM, metabolic drug, increases insulin sensitivity, decreases tost, enables LH surg
Surface epithelial cell ovarian neoplasm Frequency Proportion of Malignant ovarian tumors Age Types
Frequency: 65-70%
Proportion of Malignant ovarian tumors : 90%
Age: 20+
Types: Serous, Mucinous, Endometrioid, Brenner
Benign Serous Epithelial tumor (cystadenomas) vs Malignant Serous epithelial tumor (cystadenocarcinomas)
Benign 60% 30-40 yrs gross: single cavity or multilocular histology: single layer all columnar cells
Malignant
30%
45-60 yrs
Gross: bulky tumors
Histology: complex papillary formations, invasive of stroma
-Psammoma bodies-concentrically laminated concentrations
Bilateral tumors: more common
Benign Mucinous epithelial tumor (cystadenomas)
vs malignant epithelial tumor (cystadenocarcinomas)
Benign 80% 30-40 yrs Gross: usually multicystic Histology: mucin producing epithelial cells
Malignant 10% 45-60yrs Gross: bulk tumors Histology: complex architecture(solid and cystic cut surface), cytologic atypia, stromal invasion
Bilateral tumors: less common
What are risk factors for cystadenocarcinomas?
- nulliparity(repeated disruption and repair of epithelial surface), family history, germline mutations of tumor suppressor genes
- 5-10% familial BRCA1, BRCA2 mutations
- overall poor prognosis-mucinous a little better than serous
- tumor marker CA125-monitor response and recurrence
Endometrioid Surface epithelial tumor Behavior Gross Histology Associated Tumor Suppressor gene May arise from
Behavior
-usually malignant
Gross
-solid or cystic
Histology
-glands similar to endometrium
Associated Tumor Suppressor
gene
-PTEN
May arise from
-PCOS, obesity–excess estrogen
Brenner Surface epithelial tumor
Behavior
Gross
Histology
Behavior
-usually benign
Gross
-unilateral, solid, pale-yellow, encapsulated
Histology
-Nests of transitional-type epithelium****-resembling that of urinary tract
Germ cell ovarian neoplasms
Frequency: 15-20%
Proportion of Malignant ovarian tumors : 3-5%
Age: 0-25+ years
Types: Teratoma, Dysgerminoma, Endodermal Sinus Tumor, Choriocarcinoma, Embryonal Carcinoma
Benign Mature Teratoma vs Malignant vs Immature Teratoma
Benign 90% of teratomas Derived from all germ layers -ectoderm, endoderm, mesoderm -struma ovarii-large portion of thyroid tissue (hyperthyroid)
Malignant
1% of mature teratomas undergo malignant transformation
-squamous cell carcinoma, thyroid carcinoma, melanoma
Immature Teratoma
Presence of immature tissue (usually neuronal)
-bulky necrotic tumors
Dysgerminoma Behavior: Gross: Histological: Tumor marker:
Behavior: malignant, radiosensitive Gross: solid mass Histological: large, cells, clear cytoplasm, stroma with lymphocytes Tumor marker: LDH Male counterpart=testis seminoma -associated with gonadal dysgenesis
Endodermal SInus Tumor (yolk sac tumor) Behavior:
Gross:
Histological:
Tumor marker:
Behavior: Malignant
Gross: Friable mass
Histological: Schiller-Duvall Bodies** (glomerulus like structure)
Tumor marker: AFP
Choriocarcinoma Behavior: Gross: Histological: Tumor marker:
Behavior: Malignant, early metastasis, often fatal
Gross: small, hemorrhagic
Histological:like placental tissue with trophoblasts and syncytiotrophoblast, NO VILLI
Tumor marker: hCG
Pure choriocarcinoma rare: usually component of another germ tumor
Embryonal Carcinoma
Behavior:
Gross:
Histological:
Behavior: malignant, aggressive
Gross: unilateral mass
Histological: large primitive cells
Sex-Cord Stromal ovarian neoplasms
Frequency: 5-10%
Proportion of Malignant ovarian tumors: 2-3%
All ages
Types: Fibroma, Granulosa, Sertoli-leydig cell tumor
- originate from undifferentiated gonadal mesenchyme
- most benign, low malignant potential
- hormonally active